好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

CSF Profiles of Immunocompromised Patients with Bacterial and Viral Meningitis
Infectious Disease
P3 - Poster Session 3 (11:45 AM-12:45 PM)
10-003

This retrospective pilot study seeks to characterize cerebrospinal fluid profiles (CSF) of immunocompetent versus immunocompromised patients with confirmed infectious meningitis/encephalitis.  


There are widely accepted ranges of typical CSF values used to guide diagnosis and treatment of suspected infectious meningitis/encephalitis in healthy individuals. However, it is unclear whether these values should routinely be applied to immunocompromised patients. Atypical CSF profiles may impact timely diagnostics, treatment, and clinical outcomes.  


A retrospective database of patients with confirmed infectious bacterial or viral meningitis/encephalitis, admitted between 2010-2021, was constructed. Patients ≥18 years old, identified via ICD-9/10 codes for infectious meningitis/encephalitis were included. Demographic data, serum, CSF, imaging, and clinical data including immune status were collected.  


Of 65 definitive bacterial meningitis/encephalitis cases, 42 patients were immunocompromised.  Immunocompromised patients had a mean adjusted CSF WBC count of 2366 cells/μL ± 537 with 91.9 ± 20.9% neutrophils, CSF protein of 241.5 mg/dL ± 32.7, and glucose ratio of 0.33 ± 0.05. Immunocompetent patients had a mean CSF WBC count of 3323 cells/μL ± 1244 with 75.7% ± 6.5% neutrophils, CSF protein of 321.4 mg/dL ± 61.4, and glucose ratio of 0.32 ± 0.06. There were 62 definitive viral meningitis/encephalitis cases. 32 patients were immunocompromised, with a mean CSF WBC count of 73.6 cells/μL ± 17.0 with 63.7% ± 3.9% lymphocytes, CSF protein of 115.8 mg/dL ± 23.2, and glucose ratio of 0.49 ± 0.02. Immunocompetent patients had a mean CSF WBC count of 468 cells/μL ± 81.8 (p<0.05) with 72.6% ± 3.6% lymphocytes, CSF protein of 105.2 mg/dL ± 6.4, and glucose ratio of 0.51 ± 0.01. 


This study suggests that immunocompromised patients with infectious meningitis/encephalitis may have differing, atypical CSF profiles; this may impact timely diagnosis and clinical course. Multi-site collaboration with pooling of retrospective databases to increase generalizability of findings and validate this hypothesis is pending.  


Authors/Disclosures
Sarah R. Thomas, MD
PRESENTER
Ms. Thomas has nothing to disclose.
Kailyn Hayes Miss Hayes has nothing to disclose.
Hai Ethan Hoang, MD (Weill Cornell Medicine) Dr. Hoang has nothing to disclose.
Kiran Thakur, MD, FAAN (Columbia University College of Physicians and Surgeons) Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio.
Rachelle Dugue, MD, PhD Dr. Dugue has nothing to disclose.